cti biopharma corp (CTIC:NASDAQ CM)
Richard E. Leigh Jr.
Former Executive Vice President and General Counsel, CTI BioPharma Corp.
|Age||Total Calculated Compensation||This person is connected to 8 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Mr. Richard E. Leigh, Jr., served as Senior Vice President, Corporate Secretary and General Counsel of Motricity Inc. from September 2008 to August 2011. Mr. Leigh served as an Executive Vice President and General Counsel of Cell Therapeutics Inc. from August 2004 to 2005 and served as its Secretary. He served as a member of Cell Therapeutics Inc.'s senior management team oversaw all legal matters related to the organization including intellectual property and corporate ...
3101 Western AvenuePhone: 206-282-7100
Seattle, Washington 98121
Board Members Memberships*
Paul H Nitze School of Advanced International Studies
School Of Law, Columbia University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ron Squarer BSc (Biochemistry), MBA||Chief Executive Officer and Director|
Array BioPharma, Inc.
|Robert I. Blum||Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern|
|James M. Gower||Chairman, Chief Executive Officer and Member of Finance Committee|
Rigel Pharmaceuticals, Inc.
|Michael M. Goldberg M.D., M.B.A.||Interim Chief Executive Officer and Director|
Navidea Biopharmaceuticals, Inc
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|$535.6K||Compensation as of Fiscal Year 2013.|